Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder

Asad Ullah Jan130 enrolled

Overview

This randomized controlled trial investigates the comparative effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy and selective serotonin reuptake inhibitors (SSRIs) in fostering post-traumatic growth among patients diagnosed with post-traumatic stress disorder (PTSD). Participants will be randomized to receive either EMDR therapy or standard SSRI pharmacotherapy. The primary objective is to evaluate the extent of psychological growth and recovery achieved through each intervention, aiming to guide future therapeutic strategies for PTSD.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

130

Conditions

PTSD - Post Traumatic Stress Disorder

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD) based on DSM-5 criteria Willingness to participate and provide informed consent Ability to comply with study procedures Exclusion Criteria: Current diagnosis of psychotic disorder, bipolar disorder, or severe major depressive episode with psychotic features Active substance use disorder within the past 6 months Severe cognitive impairment or inability to complete study assessments

Locations (2)

Combined Military Hospital

Nowshera, KPK, Pakistan

Department of Psychiatry, Combined Military Hospital Nowshera

Nowshera, KPK, Pakistan

Outcomes

Primary Outcomes

Post-Traumatic Growth (PTG) measured by Post-Traumatic Growth Inventory (PTGI)

Change in PTGI total score from baseline to 6 weeks.

Time frame: 6 weeks

Secondary Outcomes

PTSD symptom severity measured by PTSD Checklist

Change in PTSD Checklist total score from baseline to 6 weeks.

Time frame: 6 weeks